Table 6. Prevalence of outcomes in hospitalized COVID-19 patients with COPD.

	CU-AMC HDC % (95%CI)	CUIMC % (95%CI)	HealthVerity % (95%CI)	IQVIA- OpenClaims % (95%CI)	OptumEhr % (95%CI)	VA-OMOP % (95%CI)	HIRA % (95%CI)
Intensive services	30.8 (25.8-36.2)	NA	5.5 (4.5-6.7)	9.9 (9.6-10.2)	17.7 (16.6-18.8)	18.4 (17.3-19.5)	9.7 (5.9-15.6)
ARDS	72.9 (67.6-77.6)	19.0 (15.6-22.9)	25.6 (23.5-27.8)	31.7 (31.2-32.2)	50.2 (48.7-51.7)	45.9 (44.5-47.3)	<3.4
ARFS	35.1 (29.9-40.7)	16.1 (13.0-19.8)	16.3 (14.6-18.2)	23.5 (23.0-24.0)	37.4 (36.0-38.8)	34.4 (33.0-35.8)	<3.4
Cardiac arrhythmia	48.2 (42.6-53.8)	14.8 (11.8-18.4)	15.5 (13.8-17.3)	14.9 (14.5-15.3)	37.4 (36.0-38.8)	37.8 (36.4-39.2)	7.6 (4.3-13.1)
Heart failure	29.1 (24.2-34.5)	9.4 (7.0-12.5)	14.6 (13.0-16.4)	9.3 (9.0-9.6)	22.4 (21.2-23.6)	26.4 (25.1-27.7)	4.8 (2.3-9.6)
Pulmonary edema	27.8 (23.0-33.1)	6.5 (4.6-9.2)	7.0 (5.9-8.3)	10.5 (10.2-10.8)	14.2 (13.2-15.2)	8.3 (7.5-9.1)	4.1 (1.9-8.7)
Myocardial infarction	9.0 (6.3-12.8)	1.3 (0.6-2.8)	2.4 (1.8-3.3)	2.6 (2.4-2.8)	8.3 (7.5-9.1)	6.1 (5.4-6.8)	<3.4
Sepsis	40.1 (34.7-45.8)	7.6 (5.5-10.4)	14.9 (13.3-16.7)	16.9 (16.5-17.3)	25.8 (24.5-27.1)	20.3 (19.2-21.5)	5.5 (2.8-10.5)
Bleeding	13.0 (9.7-17.3)	4.5 (2.9-6.8)	6.2 (5.1-7.5)	4.8 (4.6-5.0)	10.9 (10.0-11.8)	8.3 (7.5-9.1)	6.2 (3.3-11.4)
VThE	10.7 (7.7-14.7)	4.5 (2.9-6.8)	3.5 (2.7-4.5)	2.8 (2.6-3.0)	6.3 (5.6-7.0)	7.6 (6.9-8.4)	-
PE	4.3 (2.5-7.2)	2.0 (1.0-3.8)	2.0 (1.4-2.8)	1.9 (1.8-2.1)	3.8 (3.3-4.4)	4.5 (3.9-5.1)	-
Stroke	3.3 (1.8-6.0)	3.1 (1.8-5.1)	2.9 (2.2-3.8)	2.0 (1.8-2.2)	3.4 (2.9-4.0)	3.6 (3.1-4.2)	<3.4

Grey =US database. Pink=South Korean database. Yellow=European database. SABA=short-acting beta-agonist. ARDS=acute respiratory distress syndrome. ARFS=acute renal failure syndrome. VThe=venous thromboembolic disease. PE=pulmonary embolism.